Visual outcome following chemotherapy for progressive optic pathway gliomas

Ben Shofty, Liat Ben-Sira, Sigal Freedman, Michal Yalon, Rina Dvir, Michael Weintraub, Hagit Toledano, Shlomi Constantini*, Anat Kesler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background: Optic pathway gliomas (OPG) are relatively indolent tumors that may occur sporadically or in association with neurofibromatosis 1. Treatment is initiated only when a clear clinical or radiological deterioration is documented. Chemotherapy is the standard first line of treatment. Due to the indolent nature of this tumor, the most important challenge in OPG treatment is vision preservation. Methods: In this study we determined the visual outcome of 19 patients with progressive OPGs who received chemotherapy and correlated it with imaging. Results: Mean neuro-ophthalmological follow-up is 4 years and 3 months. Indications for treatment were radiological tumor progression (6 patients), visual decline (6 patients), or both (7 patients). Fifteen patients (78%) had to change to 2nd line chemotherapy (7 due to allergies and 8 due to treatment failure). During the course of chemotherapy, 11 patients (57.8%) displayed radiological tumor progression, 4 (21.5%) demonstrated stable tumor, and 4 (21.5%) displayed tumor regression. During the follow-up period, 14 (73.6%) had an overall visual deterioration, 4 (21%) had stable vision, and 1 patient (5.2%) improved. Visual acuity was examined in 38 eyes. Seventeen eyes (47.2%) deteriorated, fourteen (38.8%) were stable, and five (13.8%) improved. Ten eyes (27.7%) deteriorated to legal blindness. There was no correlation between radiological tumor growth and visual deterioration. Conclusions: The majority of our patients, who received chemotherapy for progressive OPG, experienced a decline in their visual function. New, more effective treatments are needed in order to preserve vision in this group.

Original languageEnglish
Pages (from-to)481-485
Number of pages5
JournalPediatric Blood and Cancer
Issue number3
StatePublished - Sep 2011


  • Chemotherapy
  • Glioma
  • OPG
  • Optic pathway
  • Visual outcome


Dive into the research topics of 'Visual outcome following chemotherapy for progressive optic pathway gliomas'. Together they form a unique fingerprint.

Cite this